Drug Recall Lawyer Blog

Johnson and Johnson has issued a voluntary recall of its 1-Day Acuvue TruEye contact lenses. This recall is only for contact lens that were made in Ireland and sold in Japan, other parts of Asia, and Europe and Asia.

On this recall, Americans do not need to be particularly concerned. But all of us use Johnson & Johnson products. You don't even know half of the products you use that are made by J&J. The are ubiquitous. So the number of recalls coming from J&J in recent years on problems J&J seemingly either should have caught before putting the product on the market or should have caught sooner after the problem was noticed, is disturbing.

• More on J&J Problems (CNN)
• Johnson & Johnson on the Drug Recall Lawyer Blog

An editorial in the Carroll County Times (Maryland) provides some information about contaminated food that will surprise some: 300,000 are hospitalized and 5,000 die every year because of contaminated food.

Congress is now looking to give FDA the authority that most people thought they already had: to order food recalls.

The New York Times has an interesting editorial on efforts to put a stop to drug makers paying off generic competition to stay on the sidelines:

The underhanded tactic, known as pay for delay, occurs when a generic drug company tries to bring its product to market by challenging the patents on a brand-name drug. Rather than engage in a costly and unpredictable court battle, the brand-name manufacturer sometimes pays the challenger substantial compensation to delay marketing its drug, and the generic company often welcomes the easy, risk-free money.

U.S. District Court in Minnesota Judge John R. Tunnheim denied a motion for summary judgment in a suit filed by Johnson & Johnson in a Levaquin lawsuit set for trial.

J&J's argument was the classic "doctor would have prescribed it anyway even if he knew of the risks" defense. But, according to this LawyerUSA article, the Plaintiff's treating doctor did testify that he would have approached his patient's case differently if he had know that Levaquin had greater tendon toxicity.

Plaintiff's Levaquin lawsuit alleges - as most of the claims involving Levaquin do - that the drug causes tendonitis, tendinopathy and tendon ruptures.

There is a recall of two lots of ibuprofen lysine (NeoProfen) because to unwanted levels of visible particulate matter found when testing the drug. The concern is that the matter can blog blood vessels, causing heart complications, pulmonary emboli or cause anaphylactic reactions. The potential harm can be serious but there have been no reports (that I have seen) of injury.